Poster SESSIONS
65
Poster, 24 June 2014
Authors are asked to present their posters during the poster sessions.
P-27
POSTER SESSION
17:15–18:45
Hall B
Neurodegeneration B
P-27-001
Pharmaceutical therapy for behavioral and
psychological symptoms of dementia (BPSD)
in inpatients
Junji Uno, Toyoke Aichi, Japan
P-27-003
Blood endotoxin in patients with AD, ace-
tyl choline metabolic enzymes, BDNF level
changes and significance of research
Bai Han, Peking, China
F. Wu, D. Han, Q. Sun, X. Shan
P-27-004
Effect of endotoxin on brain cell apoptotic
in aging rats
Bai Han, Peking, China
F. Wu, N. Zhao, Q. Sun, X. Shan
P-27-005
Effects of IETM on learning memory ability
and hippocampal gene expression of APP
and PS1 in rats with Alzheimer‘s disease
Bai Han, Peking, China
F. Wu, D. Han, Q. Sun, X. Shan
P-27-006
The change of endotoxin, AchE, ChAT and
Tau protein in patients with Alzheimer‘s
disease
Bai Han, Peking, China
F. Wu, D. Han, N. Zhao, Q. Sun, X. Shan
P-27-007
The role of P38, JNK and NF-KB in LPS acti-
vating microglia in Alzheimer disease‘s rats
Bai Han, Peking, China
F. Wu, D. Han, Q. Sun, X. Shan
P-27-009
Novel 5-HT6 receptor antagonists/D2 recep-
tor partial agonists targeting behavioral and
psychological symptoms of dementia
Marcin Kolaczkowski, Czosnow, Poland
M. Marcinkowska, A. Bucki, M. Pawlowski,
A. Wesolowska, P. Mierzejewski, P. Bienkowski
P-28
POSTER SESSION
17:15–18:45
Hall B
Neuropathology / post mortem studies
P-28-001
Abnormal fatty acid composition in the fron-
topolar cortex of affective disorders – Krae-
pelin‘s dichotomy still alive
Yoshitaka Tatebayashi, Tokyo, Japan
Y. Matsuda, N. Kikuchi-Nihonmatsu
P-28-002
Cytokine expression in cingulate cortex in
major depressive disorder with and with-
out psychosis
Clare Beasley, Vancouver, Canada
C. Ma, L. Shao
P-28-003
Frontal white matter measures are un-
changed in adult rats exposed to a 4-day
alcohol binge protocol
Clare Beasley, Vancouver, Canada
C. Hercher, L. Shao, T. Bendyshe-Walton, S. Fa-
zeli, C. MacRae, D. Lang
P-28-004
Trace amine-associated receptor, type 1
(TAAR1) as prospective target receptor for
neuroleptics: From D-neuron study in post-
mortem brains of schizophrenia
Keiko Ikemoto, Iwaki, Japan
P-28-005
Changes in phospholipase c beta 1 expres-
sion in the dorsolateral pre-frontal cortex in
schizophrenia and suicide
Madhara Udawela, Parkville, Australia
E. Scarr, B. Dean
P-28-006
Gene coexpression analysis in the frontal
cortex of bipolar patients and controls
Lilah Toker, Vancouver, Canada
P. Pavlidis
P-28-007
Pyruvate dehydrogenase beta subunit ex-
pression within the schizophrenia‘s
Natalie Thomas, Melbourne, Australia
E. Scarr, B. Dean
P-28-008
Class II metabotropic glutamate receptors are
downregulated in major depressive disorder
Caitlin McOmish, Melbourne, Australia
S. Hopper, G. Pavey, M. Udawela, E. Scarr,
B. Dean
